Biomarkers | Biopsy | Diagnosis | Europe | International
Diagnostic Accuracy of Lung Fluid Tests for Mesothelioma
Researchers in Germany say the diagnostic accuracy of lung fluid tests for mesothelioma is high enough that they can be…
Europe | International | New Studies | Research | Symptoms | Treatments
Follow-Up Care for Mesothelioma: What Happens After Treatment?
A new UK study on follow-up care for mesothelioma finds that patients need more continuity, timely information, and more input…
The Role of Asbestos in Mesothelioma Development in Nordic Countries
A new study of pleural mesothelioma in Nordic countries highlights the critical role of asbestos in mesothelioma development. Asbestos is…
Mesothelioma Histology Impacts Response to Chemotherapy
Response to chemotherapy for people with malignant mesothelioma may depend – at least in part – on the histology or…
Asbestos | Europe | International | New Studies | Research
Mesothelioma Risk to War Survivors Highlighted by Journalist’s Case
A new Italian case study highlights the mesothelioma risk to war survivors, including journalists and bystanders. In an article in…
CBD Oil for Mesothelioma? New Case Study Suggests It’s Possible
The case study of a UK lung cancer patient whose tumor shrunk while she was taking CBD oil could be…
Relapsed Mesothelioma Patients Live Longer on Opdivo in Phase 3 Trial
A multi-center British study suggests that the cancer drug Opdivo (nivolumab) may be a solid second-line treatment option for relapsed…
Asbestos Deaths in Italy Top 4,000 Per Year Decades After Ban
Researchers in Italy say there were 4,400 asbestos deaths in the country between 2010 and 2016 – more than two…
Chemotherapy | Europe | International | Surgery | Treatments
HITOC for Mesothelioma: Benefits May Outweigh the Risk
The benefits of a localized chemotherapy regimen known as HITOC for mesothelioma outweigh the small risk of kidney failure for…
Europe | International | New Drugs | New Studies | Research | Treatments
Second-Line Treatment with Ramucirumab Improves Mesothelioma Survival
New evidence suggests that second-line treatment with ramucirumab after first-line chemotherapy may lead to longer survival in people with pleural…